Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$16.36 - $21.39 $6.71 Million - $8.78 Million
-410,340 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$16.93 - $26.22 $793,390 - $1.23 Million
-46,863 Reduced 10.25%
410,340 $7.63 Million
Q1 2019

May 13, 2019

BUY
$23.15 - $28.34 $10.6 Million - $13 Million
457,203 New
457,203 $11.2 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $127M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Ws Management Lllp Portfolio

Follow Ws Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Ws Management Lllp with notifications on news.